OTC · Financial Statements

Glucose Health, Inc. (GLUC) Financial Statements

$0.40 OTC: GLUC Market Cap $6.72M

Glucose Health, Inc. most recently reported annual revenue of $0, net profit of $0. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric20212022202320242025
Revenue$1.0M$1.0M$1.0M$0$0
Operating Profit$0$-1.0M$0$0$0
Net Profit$0$-1.0M$0$0$0
EPS$-0.03$-0.05$-0.03$-0.03$-0.02
Op Margin-35.2%-52.4%-78.9%-79.8%-58.6%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$1.0M$1.0M$0$0$0
Total Liabilities$0$0$0$0$0
Cash$1.0M$0$0$0$0
Borrowings$0$0$0$0$0

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$0$0$0$0$0
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$1.0M$0$0$0$0
Free Cash Flow$0$0$0$0$0

Valuation & Return Ratios

MetricValue
PEG Ratio-0.48
EV / EBITDA-23.02
FCF Yield-1.17%
Quick Ratio3.59
Interest Coverage-10.70
Return 1Y295.00%
Return 3Y31.23%
Return 5Y-85.58%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Consumer Defensive StocksLow P/E Consumer Defensive StocksHigh Net Margin Consumer Defensive StocksDividend Consumer Defensive StocksLow Debt Consumer Defensive StocksAll stock screens
GLUC Overview GLUC Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.